These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32015459)

  • 1. Association of HSPA1B genotypes with psychopathology and neurocognition in patients with the first episode of psychosis: a longitudinal 18-month follow-up study.
    Bosnjak Kuharic D; Bozina N; Ganoci L; Makaric P; Kekin I; Prpic N; Bozina T; Rojnic Kuzman M
    Pharmacogenomics J; 2020 Oct; 20(5):638-646. PubMed ID: 32015459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of CNR1 genotypes with changes in neurocognitive performance after eighteen-month treatment in patients with first-episode psychosis.
    Rojnic Kuzman M; Bosnjak Kuharic D; Ganoci L; Makaric P; Kekin I; Rossini Gajsak L; Prpic N; Bozina T; Bajic Z; Bozina N
    Eur Psychiatry; 2019 Sep; 61():88-96. PubMed ID: 31398679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychotic symptoms, cognition and affect as predictors of psychosocial problems and functional change in first-episode psychosis.
    Stouten LH; Veling W; Laan W; van der Helm M; van der Gaag M
    Schizophr Res; 2014 Sep; 158(1-3):113-9. PubMed ID: 25008791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: role of dopamine, serotonin and glutamate candidate genes.
    Mas S; Gassó P; Lafuente A; Bioque M; Lobo A; Gonzàlez-Pinto A; Olmeda MS; Corripio I; Llerena A; Cabrera B; Saiz-Ruiz J; Bernardo M;
    Pharmacogenomics J; 2016 Oct; 16(5):439-45. PubMed ID: 27272046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients.
    Mas S; Gassó P; Torra M; Bioque M; Lobo A; González-Pinto A; Olmeda MS; Corripio I; Vieta E; Castro-Fornieles J; Rodriguez-Jimenez R; Bobes J; Usall J; Llerena A; Saiz-Ruiz J; Bernardo M; Lafuente A; PEPs Group
    Eur Neuropsychopharmacol; 2017 Jul; 27(7):647-656. PubMed ID: 28389049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Pre-onset Subthreshold Psychotic Symptoms With Longitudinal Outcomes During Treatment of a First Episode of Psychosis.
    Rosengard RJ; Malla A; Mustafa S; Iyer SN; Joober R; Bodnar M; Lepage M; Shah JL
    JAMA Psychiatry; 2019 Jan; 76(1):61-70. PubMed ID: 30304442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study.
    Mayoral-van Son J; de la Foz VO; Martinez-Garcia O; Moreno T; Parrilla-Escobar M; Valdizan EM; Crespo-Facorro B
    J Clin Psychiatry; 2016 Apr; 77(4):492-500. PubMed ID: 26759992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychopathology, cognition and outcome in Dutch and immigrant first-episode psychosis patients.
    Stouten LH; Veling W; Laan W; Van der Gaag M
    Early Interv Psychiatry; 2019 Jun; 13(3):646-656. PubMed ID: 29603625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of delaying treatment of first-episode psychosis on symptoms and social outcomes: a longitudinal analysis and modelling study.
    Drake RJ; Husain N; Marshall M; Lewis SW; Tomenson B; Chaudhry IB; Everard L; Singh S; Freemantle N; Fowler D; Jones PB; Amos T; Sharma V; Green CD; Fisher H; Murray RM; Wykes T; Buchan I; Birchwood M
    Lancet Psychiatry; 2020 Jul; 7(7):602-610. PubMed ID: 32563307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial and adverse effects of antipsychotic medication on cognitive flexibility are related to COMT genotype in first episode psychosis.
    Nelson CLM; Amsbaugh HM; Reilly JL; Rosen C; Marvin RW; Ragozzino ME; Bishop JR; Sweeney JA; Hill SK
    Schizophr Res; 2018 Dec; 202():212-216. PubMed ID: 29941295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General Functioning in Patients With First-Episode Psychosis After the First 18 Months of Treatment.
    Rojnic Kuzman M; Makaric P; Bosnjak Kuharic D; Kekin I; Madzarac Z; Koricancic Makar A; Bajic Z; Ostojic D; Silic A; Zivkovic M
    J Clin Psychopharmacol; 2020; 40(4):366-372. PubMed ID: 32639289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different neurocognitive profiles of risperidone and aripiprazole in the FIRST episode of psychosis: A 3-year follow-up comparison.
    Setién-Suero E; Ortiz-García de la Foz V; Suárez-Pinilla P; Crespo-Facorro B; Ayesa-Arriola R
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110309. PubMed ID: 33775745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining disorganization in patients with first episode psychosis: Findings from a 1-year follow-up of the 'Parma early psychosis' program.
    Pelizza L; Leuci E; Maestri D; Quattrone E; Azzali S; Paulillo G; Pellegrini P
    Early Interv Psychiatry; 2022 May; 16(5):552-560. PubMed ID: 34279049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of guided discontinuation of antipsychotics on neurocognition in first onset psychosis.
    Faber G; Smid HG; Van Gool AR; Wiersma D; Van Den Bosch RJ
    Eur Psychiatry; 2012 May; 27(4):275-80. PubMed ID: 21561741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consequences of persistent depression and apathy in first-episode psychosis - A one-year follow-up study.
    Lyngstad SH; Gardsjord ES; Simonsen C; Engen MJ; Romm KL; Melle I; Færden A
    Compr Psychiatry; 2018 Oct; 86():60-66. PubMed ID: 30081208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant salience in first-episode psychosis: Longitudinal stability and treatment-response.
    Scazza I; Pelizza L; Azzali S; Garlassi S; Paterlini F; Chiri LR; Poletti M; Pupo S; Raballo A
    Early Interv Psychiatry; 2022 Aug; 16(8):912-919. PubMed ID: 34786863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis.
    Zhang JP; Robinson D; Yu J; Gallego J; Fleischhacker WW; Kahn RS; Crespo-Facorro B; Vazquez-Bourgon J; Kane JM; Malhotra AK; Lencz T
    Am J Psychiatry; 2019 Jan; 176(1):21-28. PubMed ID: 30392411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depressive symptoms in first-episode psychosis: a 10-year follow-up study.
    Sönmez N; Røssberg JI; Evensen J; Barder HE; Haahr U; Ten Velden Hegelstad W; Joa I; Johannessen JO; Langeveld H; Larsen TK; Melle I; Opjordsmoen S; Rund BR; Simonsen E; Vaglum P; McGlashan T; Friis S
    Early Interv Psychiatry; 2016 Jun; 10(3):227-33. PubMed ID: 24956976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between rostral prefrontal cortical activity and functional outcome in first-episode psychosis: a longitudinal functional near-infrared spectroscopy study.
    Koike S; Satomura Y; Kawasaki S; Nishimura Y; Takano Y; Iwashiro N; Kinoshita A; Nagai T; Natsubori T; Tada M; Ichikawa E; Takizawa R; Kasai K
    Schizophr Res; 2016 Feb; 170(2-3):304-10. PubMed ID: 26792296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis.
    Sacchetti E; Magri C; Minelli A; Valsecchi P; Traversa M; Calza S; Vita A; Gennarelli M
    Pharmacogenomics J; 2017 Mar; 17(2):146-154. PubMed ID: 26856250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.